Developing a novel inhaled therapeutic for the treatment of bronchiolitis obliterans syndrome

Developing a novel inhaled therapeutic for the treatment of bronchiolitis obliterans syndrome

Breath Therapeutics – a Zambon Group Company, is a clinical stage biopharmaceutical company specialising in advanced inhaled therapeutics for severe respiratory diseases. The company’s proprietary liposomal drug formulation has been specifically designed for inhaled administration with an exclusively licensed nebulizer technology. Liposomal cyclosporine A for inhalation (L-CsA-i), an investigational drug, is advancing in phase 3 clinical trials as the first […]

Read More…